1-4 of 4
Adrian Bloor, MA MB BChir PhDFCRP FRCPath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Haploidentical Transplantation Using High Dose Post-Transplant Cyclophosphamide for Patients with Aplastic Anemia : The European Group for Blood and Marrow Transplantation Experience

Pedro H Prata, MD, Boris Afanasyev, Dirk-Jan Eikema, Frans Smiers, Cora Knol, Jose L. Diez-Martin, MD PhD, Vanderson G. Rocha, MD PhD, Yener Koc, Xavier Poire, MD, Nathalie Fegueux, Nicolaus Kröger, MD, Wolfgang Holter, MD, Adrian Bloor, MA MB BChir PhDFCRP FRCPath, Charlotte Jubert, MD, Amal Al-Seraihy, MD, Arnold Ganser, MD, Herve Tilly, MD, Pietro Pioltelli, MD, José A. Pérez-Simón, MD PhD, Aloysius YL Ho, MBBS,FRCP,FRCPath, Mahmoud Aljurf, MD, Nigel H. Russell, Hélène Labussière-Wallet, Tessa Kerre, MD, Carlo Dufour, MD, Regis Peffault De Latour
Journal: Blood
Blood (2018) 132 (Supplement 1): 486.
https://doi.org/10.1182/blood-2018-99-114033
Published: 2018
Journal Articles

Preliminary Data on Safety, Cellular Kinetics and Anti-Leukemic Activity of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a Pool of Adult and Pediatric Patients with High-Risk CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Reuben Benjamin, Charlotte Graham, MRCP, BSc, MBBS, Deborah Yallop, MBBS FRCP FRCPath PhD, Agnieszka Jozwik, Oana Ciocarlie, Nitin Jain, MD, Elias J. Jabbour, MD, Marcela V. Maus, MD PhD, Matthiew Frigault, MD MSc, Nicolas Boissel, MD PhD, Jerome Larghero, PharmD, PhD, Andre Baruchel, MD, Mohamad Mohty, MD PhD, Barbara De Moerloose, MD PhD, Adrian Bloor, MA MB BChir PhDFCRP FRCPath, Noelle V. Frey, MD, Amina Zinaï, MD, Svetlana Balandraud, MD, Anne Philippe, Pharm D, Sylvain Fouliard, Ludiane Gauthier, Jeanne Pauly, PharmD, Cyril Konto, MD, Candy Bermingham, PhD, Paul Veys, MD PhD, Waseem Qasim, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 896.
https://doi.org/10.1182/blood-2018-99-111356
Published: 2018
Journal Articles

Ibrutinib and Obinutuzumab in CLL: Improved MRD Response Rates with Substantially Enhanced MRD Depletion for Patients with >1 Year Prior Ibrutinib Exposure

Andy Rawstron, PhD, Talha Munir, Kristian Brock, MSc, BSc, Nichola Webster, Samuel Munoz Vicente, MSc, Francesca Yates, PhD, Sophie Cramp, MSc, BSc, Rebecca Bishop, BSc, Surita Dalal, PhD, Ruth M De Tute, BSc,MSc, Oonagh Sheehy, Andrew Pettitt, FRCPath, PhD, Christopher P. Fox, MD PhD, Stephen Devereux, PhD, Christopher Fegan, MD, Donald MacDonald, Adrian Bloor, MA MB BChir PhDFCRP FRCPath, Peter Hillmen, MB ChB, PhD FRCP, FRCPath
Journal: Blood
Blood (2018) 132 (Supplement 1): 181.
https://doi.org/10.1182/blood-2018-181
Published: 2018
Journal Articles

Ibrutinib Plus Venetoclax in Relapsed/Refractory CLL: Results of the Bloodwise TAP Clarity Study

Peter Hillmen, MB ChB, PhD FRCP, FRCPath, Andy Rawstron, BSc, PhD, Kristian Brock, MSc, BSc, Samuel Munoz Vicente, MSc, Francesca Yates, PhD, Rebecca Bishop, BSc, Donald Macdonald, Christopher Fegan, MD, Alison McCaig, PhD, Anna Schuh, MD PhD, Andrew Pettitt, FRCPath, PhD, John G. Gribben, Piers E.M. Patten, BSc, MRCP, MRCPath, PhD, Stephen Devereux, PhD, Adrian Bloor, MA MB BChir PhDFCRP FRCPath, Christopher P. Fox, MD PhD, Francesco Forconi, MD DM, PhD FRCPath, Talha Munir
Journal: Blood
Blood (2018) 132 (Supplement 1): 182.
https://doi.org/10.1182/blood-2018-182
Published: 2018